Product Carbon Footprint: Enabling Product-Level Decarbonization in Biopharma
Scope 3 emissions dominate the biopharma carbon footprint, making product-level visibility more critical than ever.
In this whitepaper, Jimin Han, Director of ESG at Samsung Biologics, explores how Product Carbon Footprint (PCF) enables targeted, data-driven decarbonization.
Key highlights:
Data-enabled rigor: A structured, automated PCF system that quantifies product-level emissions with consistent accuracy
Decision-making support: Actionable insights to inform process evaluation, supplier selection, and evolving regulatory and disclosure requirements
Net-zero alignment: PCF as a core metric to track progress toward Samsung Biologics’ net-zero greenhouse gas target by 2050
Scope 3 emissions dominate the biopharma carbon footprint, making product-level visibility more critical than ever.
In this whitepaper, Jimin Han, Director of ESG at Samsung Biologics, explores how Product Carbon Footprint (PCF) enables targeted, data-driven decarbonization.
Key highlights:
Data-enabled rigor: A structured, automated PCF system that quantifies product-level emissions with consistent accuracy
Decision-making support: Actionable insights to inform process evaluation, supplier selection, and evolving regulatory and disclosure requirements
Net-zero alignment: PCF as a core metric to track progress toward Samsung Biologics’ net-zero greenhouse gas target by 2050
Related Content